International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions

Author： Kutcher S.   Aman M.   Brooks S.J.   Buitelaar J.   van Daalen E.   Fegert J.   Findling R.L.   Fisman S.   Greenhill L.L.   Huss M.   Kusumakar V.   Pine D.   Taylor E.   Tyano S.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.14, Iss.1, 2004-01, pp. : 11-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Modafinil: A Treatment Alternative for Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

By  

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 5-7

Guilford Publications Inc

Access to resources Recommend Favorite

New drugs for treatment of attention-deficit/hyperactivity disorder

By Chung Bowen   Suzuki Alejandra R   McGough James J  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 269-276

Informa Healthcare

Access to resources Recommend Favorite

New drugs for the treatment of attention-deficit/hyperactivity disorder

By Pataki Caroly S   Feinberg David T   McGough James J  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 293-302

Informa Healthcare

Access to resources Recommend Favorite

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD)

By Sallee Floyd R   Eaton Katherine  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2549-2556

Informa Healthcare

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death

By Besag Frank M.C.  

Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. : 1097-1100

Adis International

Access to resources Recommend Favorite